CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Xolairdrug
Likely dose
XolairAI-extracted
Key inclusion· 2
  • ✓Mild asthma
  • ✓Adult age
Key exclusion· 2
  • ✕Children
  • ✕Current use of inhaled or systemic steroids

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00189228
NCT00189228N/ACompleted
CompareCT.gov

Not a Drug Trial. We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma

University of New Mexico·interventional·Posted Sep 16, 2005·Updated Sep 27, 2019

In Brief

A clinical study evaluating Xolair for Asthma. Completed, enrolled 18 participants across 1 site.

Detailed Summary

We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartSep 1, 2005
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 20.8 years ago

Interventions

Xolairdrug

Patients are administered Xolair